NGL Fine-Chem Limited (NSE:NGLFINE)
India · Delayed Price · Currency is INR 2,900.00
-34.80 (-1.19%)
Nov 11, 2026, 1:19 PM IST
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 17.9 billion as of November 10, 2026. Its market cap has increased by 95.01% in one year.
Market Cap
17.90B
Enterprise Value
18.72B
Revenue
5.75B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.04
ChartMarket Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 17.90B, an increase of 22,162.28%. That is a compound annual growth rate of 28.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 17.90B | 105.62% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 293.27B |
| Pfizer | 179.24B |
| CORONA Remedies | 155.31B |
| Marksans Pharma | 139.91B |
| Sanofi Consumer Healthcare India | 79.44B |
| Senores Pharmaceuticals | 54.11B |
| SMS Pharmaceuticals | 48.06B |
| Sai Parenteral's | 22.36B |